Literature DB >> 1624800

Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells.

G Rodriguez-Tarduchy1, M K Collins, I García, A López-Rivas.   

Abstract

The death of hemopoietic cells on withdrawal of CSF occurs by a mechanism known as apoptosis characterized by the early degradation of chromatin into oligonucleosome-length fragments. Insulin-like growth factor I plays a pivotal role in the regulation of somatic cell growth as a mediator of growth hormone action. Animals with low levels of circulating IGF-I are more vulnerable to infections and have diminished immune responses. To analyze the possibility of a regulatory role of IGF-I on hemopoiesis and determine its mechanism of action, we have studied the effect of this growth factor on the survival and proliferation of two IL-3-dependent hemopoietic cell lines and in IL-3-responsive primary cultures of bone marrow-derived mast cells. In IL-3-depleted cultures, IGF-I prevented DNA fragmentation and apoptotic cell death. Insulin at high concentration had a weak protective action and IGF-II was inactive in suppressing apoptosis in these IL-3-dependent hemopoietic cells. Cell proliferation was also stimulated by IGF-I in the absence of other hemopoietic growth factors although it was a weak mitogen when compared with IL-3. These results indicate that circulating or locally produced IGF-I may promote survival of both the steady state hemopoietic precursor population and cytokine-producing cells and could therefore regulate hemopoiesis acting in a concerted manner with other CSF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624800

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Regulation of Id gene expression by type I insulin-like growth factor: roles of Stat3 and the tyrosine 950 residue of the receptor.

Authors:  M Prisco; F Peruzzi; B Belletti; R Baserga
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Insulin-like growth factor-1 activates Akt and Jun N-terminal kinases (JNKs) in promoting the survival of T lymphocytes.

Authors:  Patrick T Walsh; Loraine M Smith; Rosemary O'Connor
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

3.  Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy.

Authors:  Q Li; B Li; X Wang; A Leri; K P Jana; Y Liu; J Kajstura; R Baserga; P Anversa
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 4.  Critical signal transduction pathways in CLL.

Authors:  Asish K Ghosh; Neil E Kay
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

5.  The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal.

Authors:  M Prisco; A Hongo; M G Rizzo; A Sacchi; R Baserga
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

6.  Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt.

Authors:  G Kulik; A Klippel; M J Weber
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 7.  The IGF-I receptor and cancer.

Authors:  R Baserga; M Resnicoff; M Dews
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

8.  Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.

Authors:  A Ly; H T Duc; M Kalamarides; L A Trojan; Y Pan; A Shevelev; J C François; T Noël; A Kane; D Henin; D D Anthony; J Trojan
Journal:  Mol Pathol       Date:  2001-08

9.  Preparation of a recombinant chimaera of insulin-like growth factor II and interleukin 3 with high proliferative potency for haemopoietic cells.

Authors:  M R Difalco; L F Congote
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

10.  Growth hormone mitigates against lethal irradiation and enhances hematologic and immune recovery in mice and nonhuman primates.

Authors:  Benny J Chen; Divino Deoliveira; Ivan Spasojevic; Gregory D Sempowski; Chen Jiang; Kouros Owzar; Xiaojuan Wang; Diane Gesty-Palmer; J Mark Cline; J Daniel Bourland; Greg Dugan; Sarah K Meadows; Pamela Daher; Garrett Muramoto; John P Chute; Nelson J Chao
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.